Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMID 10522948)

Published in J Am Geriatr Soc on October 01, 1999

Authors

D C Steffens1, M C Norton, B L Plassman, J T Tschanz, B W Wyse, K A Welsh-Bohmer, J C Anthony, J C Breitner

Author Affiliations

1: Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA.

Articles citing this

Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review. BMC Neurol (2006) 1.27

Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol (2013) 1.10

Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci (2006) 1.05

Comparative cognitive and subjective side effects of immediate-release oxycodone in healthy middle-aged and older adults. J Pain (2009) 0.92

Building a better hormone therapy? How understanding the rapid effects of sex steroid hormones could lead to new therapeutics for age-related memory decline. Behav Neurosci (2012) 0.92

The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease. J Med Genet (2004) 0.84

The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset. Int Rev Psychiatry (2013) 0.84

Impaired cognition and attention in adults: pharmacological management strategies. Neuropsychiatr Dis Treat (2007) 0.83

APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study. Int J Geriatr Psychiatry (2008) 0.83

Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83

The associations of hormone replacement therapy and preventive practices in minority women. J Natl Med Assoc (2005) 0.76

Cognitive performance and estrogen use in nondemented older women. J Am Geriatr Soc (1999) 0.75

Articles by these authors

Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA (1993) 12.83

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry (1997) 8.01

The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr (1991) 7.05

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology (1999) 4.37

Probing the meaning of racial/ethnic group comparisons in crack cocaine smoking. JAMA (1993) 4.29

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry (2000) 4.23

Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology (2000) 3.61

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet (1996) 3.58

Psychopathology and attrition in the epidemiologic catchment area surveys. Am J Epidemiol (1992) 3.54

Prevalence of substance use among US physicians. JAMA (1992) 3.51

Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry (1997) 3.48

Limits of the 'Mini-Mental State' as a screening test for dementia and delirium among hospital patients. Psychol Med (1982) 3.36

Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18

Impact of parent monitoring on initiation of drug use through late childhood. J Am Acad Child Adolesc Psychiatry (1996) 3.11

Neighborhood environment and opportunity to use cocaine and other drugs in late childhood and early adolescence. Drug Alcohol Depend (1996) 3.08

Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol (1998) 2.92

Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1995) 2.74

FDG PET imaging in patients with pathologically verified dementia. J Nucl Med (2000) 2.70

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J (2009) 2.66

Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Int J Geriatr Psychiatry (2001) 2.63

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57

Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology (2007) 2.56

Screening for psychosis in the general population with a self-report interview. J Nerv Ment Dis (1991) 2.56

Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology (2002) 2.52

Mental health and social characteristics of the homeless: a survey of mission users. Am J Public Health (1986) 2.50

The meaning of cognitive impairment in the elderly. J Am Geriatr Soc (1985) 2.43

Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry (1984) 2.26

A different kind of contextual effect: geographical clustering of cocaine incidence in the USA. J Epidemiol Community Health (2003) 2.08

Vascular factors predict rate of progression in Alzheimer disease. Neurology (2007) 2.06

Characteristics of nonresponders in a community survey of the elderly. J Am Geriatr Soc (1994) 2.05

APOE genotype predicts when--not whether--one is predisposed to develop Alzheimer disease. Nat Genet (1998) 2.05

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology (1994) 2.04

Age differences in the symptoms of depression: a latent trait analysis. J Gerontol (1994) 2.02

Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction (1993) 2.01

Alzheimer's disease in the NAS-NRC Registry of aging twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med (1995) 2.01

Depression without sadness: functional outcomes of nondysphoric depression in later life. J Am Geriatr Soc (1997) 2.00

A case-control study of Alzheimer's disease in Australia. Neurology (1990) 1.98

Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry (2000) 1.97

Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology (2010) 1.95

Developmental epidemiologically based preventive trials: baseline modeling of early target behaviors and depressive symptoms. Am J Community Psychol (1991) 1.94

Targeting early antecedents to prevent tobacco smoking: findings from an epidemiologically based randomized field trial. Am J Public Health (1998) 1.94

Characterizing food usage by demographic variables. J Am Diet Assoc (1982) 1.90

Male-female differences in the earliest stages of drug involvement. Addiction (1999) 1.86

Parent monitoring and the incidence of drug sampling in urban elementary school children. Am J Epidemiol (1995) 1.86

The inner city and drug use: initial findings from an epidemiological study. Drug Alcohol Depend (1997) 1.85

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.82

Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry (1986) 1.80

The design of the Epidemiologic Catchment Area surveys. The control and measurement of error. Arch Gen Psychiatry (1984) 1.79

Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol (1997) 1.76

An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease. Int J Geriatr Psychiatry (2001) 1.75

The uniqueness of the DSM definition of post-traumatic stress disorder: implications for research. Psychol Med (2002) 1.75

4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. Am J Physiol Endocrinol Metab (2000) 1.75

Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology (2006) 1.75

The NIfETy method for environmental assessment of neighborhood-level indicators of violence, alcohol, and other drug exposure. Prev Sci (2008) 1.74

Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study. Am J Psychiatry (1999) 1.73

Filters on the pathway to mental health care, II. Sociodemographic factors. Psychol Med (1995) 1.66

Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health (1991) 1.66

Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol (1990) 1.65

Tobacco smoking and depressed mood in late childhood and early adolescence. Am J Public Health (1999) 1.63

Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin. Drug Alcohol Depend (1999) 1.63

Hereditary influences on cognitive functioning in older men. A study of 4000 twin pairs. Arch Neurol (1993) 1.62

Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol (2002) 1.54

Measurement of HIV risk behaviors among intravenous drug users. Br J Addict (1992) 1.53

An epidemiologic investigation of potential risk factors for suicide attempts. Soc Psychiatry Psychiatr Epidemiol (1990) 1.52

Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up. Neurology (1995) 1.50

Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am J Drug Alcohol Abuse (1991) 1.50

Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend (1994) 1.47

Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology (1997) 1.47

Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46

Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience. Arch Pathol Lab Med (1997) 1.46

The incidence of specific DIS/DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand (1989) 1.46